Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
7.84
-0.13 (-1.63%)
Mar 13, 2026, 8:29 AM EDT - Market open
Grifols Employees
Grifols had 23,737 employees as of December 31, 2023. The number of employees decreased by 2,577 or -9.79% compared to the previous year.
Employees
23,737
Change (1Y)
-2,577
Growth (1Y)
-9.79%
Revenue / Employee
$372,166
Profits / Employee
$19,884
Market Cap
6.57B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2023 | 23,737 | -2,577 | -9.79% |
| Dec 31, 2022 | 26,314 | 3,080 | 13.26% |
| Dec 31, 2021 | 23,234 | -421 | -1.78% |
| Dec 31, 2020 | 23,655 | -348 | -1.45% |
| Dec 31, 2019 | 24,003 | 2,773 | 13.06% |
| Dec 31, 2018 | 21,230 | 2,934 | 16.04% |
| Dec 31, 2017 | 18,296 | 3,419 | 22.98% |
| Dec 31, 2016 | 14,877 | 140 | 0.95% |
| Dec 31, 2015 | 14,737 | 757 | 5.41% |
| Dec 31, 2014 | 13,980 | 2,201 | 18.69% |
| Dec 31, 2013 | 11,779 | 671 | 6.04% |
| Dec 31, 2012 | 11,108 | -122 | -1.09% |
| Dec 31, 2011 | 11,230 | 5,262 | 88.17% |
| Dec 31, 2010 | 5,968 | -16 | -0.27% |
| Dec 31, 2009 | 5,984 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Pfizer | 75,000 |
| Merck & Co. | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| GSK plc | 66,841 |
| Bristol-Myers Squibb Company | 32,500 |
| Amgen | 31,500 |
| Gilead Sciences | 17,000 |
GRFS News
- 15 hours ago - Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites - GlobeNewsWire
- 14 days ago - Grifols SA (GRFS) (Full Year 2025) Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus
- 14 days ago - Full Year 2025 Grifols SA Earnings Call Transcript - GuruFocus
- 14 days ago - Grifols (GRFS) Projects Strong Financial Performance by 2026 - GuruFocus
- 14 days ago - Grifols (GRFS) Exceeds Revenue Expectations and Gains Credit Rating Upgrades - GuruFocus
- 14 days ago - Grifols doubles net profit in 2025, driven by revenues - Reuters
- 5 months ago - Spanish court summons Gotham City founder in Grifols share price probe - Reuters
- 9 months ago - XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology - GlobeNewsWire